Summary
Three types of mutual interactions between ANP and the sympathetic activity have been identified: 1) Adrenergic atrial stimulation enhances regulated atrial ANP release; 2) the hemodynamic effects of exogenous ANP are blunted by reflex activation of sympathetic activity; 3) ANP has inhibitory actions on sympathoadrenal activity in vivo.
The direct adrenergic stimulation of regulated atrial ANP release is mediated via activation of β- and αl-adrenoceptors; it interfers with indirect effects of sympathetic activity affecting mechanical stimuli of atrial ANP release (i.e.: diastolic atrial distension and frequency of atrial contraction).
The reflex modulation of sympathetic activity during ANP-induced hypotension and the direct ANP-induced sympathoinhibition counteract each other during exogenous ANP application, but they act in concert during elevations of atrial filling, which releases ANP and concomitantly activates sympathoinhibitory reflexes. ANP can inhibit the sympathoadrenal system by several mechanisms: by activation of mechanosensitive vagal type C afferents eliciting sympathoinhibitory reflexes, by activating ANP binding sites on sympathetic ganglia and on CNS areas outside the bloodbrain barrier, and by inhibiting norepinephrine release from postganglionic nerve terminals and epinephrine release from the adrenal medulla.
The sympathoinhibition by ANP is not attenuated by prolonged elevations of circulating ANP during development of congestive heart failure, when other ANP effects are reduced due to target organ desensitation. Thus, the relative importance of the sympathoinhibition within the broad spectrum of ANP effects is augmented during prolonged ANP exposure.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Bolli P, Müller FB, Linder L, Raine AEG, Re-sink TJ, Erje P, Kiowski W, Ritz R, Bühler FR (1987) The vasodilator potency of atrial natriuretic peptide in man. Circulation 75: 221–228
Cheung DW (1988) Atriopeptin III depresses the excitability of sympathetic neurones. Biochem Biophys Res Commun 154: 411–416
Crozier IG, Ikram H, Gomez HJ, Nicholls MG, Espiner EA, Warner NJ (1986) Haemodynamic effects of atrial peptide infusion in heart failure. Lancet 11: 1242–1245
DeBold AJ (1985) Atrial natriuretic factor: a hormone produced by the heart. Science 230: 767–770
Debinski W, Kuchel O, Buu NT, Garcia R, Can-tin M, Genest J (1986a) Involvement of the adrenal glands in the action of the atrial natriuretic factor. Proc Soc Biol Med 181: 318–324
Debinski W, Kuchel O, Garcia R, Buu NT, Racz K, Cantin M, Genest J (1986b) Atrial natriuretic factor inhibits the sympathetic nervous activity in one-kidney, one-clip hypertension in the rat. Proc Soc Biol Med 181: 173–177
Debinski W, Gutkowska J, Kuchel O, Racz K, Buu NT, Cantin M, Genest J (1987a) Presence of an atrial natriuretic factorlike peptide in the rat superior cervical ganglia. Neuroendocrinology 46: 236–240
Debinski W, Kuchel O, Buu NT, Cantin M, Genest J (1987b) Atrial natriuretic factor partially inhibits the stimulated catecholamine synthesis in superior cervical ganglia of the rat. Neurosci Lett 77: 92–96
Dietz JR (1984) Release of natriuretic factor from rat heart-lung preparation by atrial distension. Am J Physiol 247: R1093 - R1096
Ebert TJ, Cowley Jr AW (1988) Atrial natriuretic factor attenuates carotid baroreflex-mediated cardioacceleration in humans. Am J Physiol 254: R590 - R594
Ebert TJ, Skelton MM, Cowley Jr AW (1988) Dynamic cardiovascular responses to infusions of atrial natriuretic factor in humans. Hypertension 11: 537–544
Ester M, Jackman G, Bobik A, Kelleher D, Jennings, G, Leonard P, Skews H, Korner P (1979) Determination of norepinephrine apparent release rate and clearance in humans. Life Sci 25: 1461–1470
Floras JS, Aylward PE, Victor RG, Mark AL, Abboud FM (1988) Epinephrine facilitates neurogenic vasoconstriction in humans. J Clin Invest 81: 1265–1274
Forssmann WG, Hock D, Lottspeich F, Henschen A, Kreye VAW, Christmann M, Reinecke M, Metz J, Carlquist M, Mutt V (1983) The right auricle of the heart is an endocrine organ: cardiodilatin as a peptide hormone candidate. Anat Embryol 168: 307–313
Genest J, Cantin M, Anand-Srivastava MB, Cusson JR, De Lean A, Garcia R, Gutkowska J, Hamlet P, Kuchel O, Larochelle P, Nemer M, Schiffrin EL, Schiller PW, Thibault G, Tremblay J (1988) The atrial natriuretic factor: its physiology and biochemistry. Rev Physiol Biochem Pharmacol 110: 1–145
Gutkind JS, Kurihara M, Castrén E, Saavedra JM (1987) Atrial natriuretic peptide receptors in sympathetic ganglia: biochemical response and alterations in genetically hypertensive rats. Biochem Biophys Res Commun 149: 65–72
von Harsdorf R, Lang R, Fullerton M, Smith AI, Woodcock EA (1988) Right heart dilatation increases inositol-(1, 4, 5)trisphosphate accumulation. Implications for the control of atrial natriuretic peptide release. FEBS Letters 233: 201–205
Holtz J, Stewart DJ, Elsner D, Bassenge E (1986) In vivo atrial peptide-venodilation: minimal potency relative to nitroglycerin in dogs. Life Sci 39: 2177–2184
Holtz J, Münzel T, Bassenge E (1987a) Das natriuretische Vorhofhormon im Menschen. Z Kardiol 76: 655–670
Holtz J, Sommer O, Bassenge E (1987b) Inhibition of sympatho-adrenal activity by atrial natriuretic factor in dogs. Hypertension 9: 350–354
Imaizumi T, Takeshita A, Higashi H, Nakamura M (1987) cc-ANP alters reflex control of lumbar and renal sympathetic nerve activity and heart rate. Am J Physiol 253:H1136–H1140
Kelly RB (1985) Pathways of protein secretion in eukaryotes. Science 230: 25–32
Koyama S, Nishida Y, Hosomi H, Abe Y (1986) Participation of baroreceptor reflexes in blood pressure and sympathetic nerve responses to a synthetic human atrial natriuretic peptide in anesthetized dogs. Bur J Pharmacol 127: 43–48
Lang RE, Thölken H, Ganten D, Luft FC, Ruskoaho H, Unger T (1985) Atrial natriuretic factor a circulating hormone stimulated by volume loading. Nature 314: 264–266
Lansman JB, Hallam TJ, Rink TJ (1987) Single stretch-activated ion channels in vascular endothelial cells as mechanotransducers? Nature 325: 811–813
MacKay MJ, Cheung DW (1987) Inhibition of neuromuscular transmission in the guinea-pig saphenous artery by atriopeptin II. Can J Physiol Pharmacol 65: 1988–1990
Mantyh CR, Kruger L, Brecha NC, Mantyh PW (1987) Localization of specific binding sites for atrial natriuretic factor in the central nervous system of rat, guinea pig, cat and human. Brain Res 412: 329–342
Molina CR, Fowler MB, McCrory S, Peterson C, Myers BD, Schroeder JS, Murad F (1988) Hemodynamic, renal and endocrine effects of atrial natriuretic peptide infusion in severe heart failure. J Am Coll Cardiol 12: 175–186
Morel G, Chabot JG, Garcia-Caballero T, Gossard F, Dihl F, Belles-Isles M, Heisler S (1988) Synthesis, internalization, and localization of atrial natriuretic peptide in rat adrenal medulla. Endocrinology 123: 149–158
Mukoyama M, Nakao K, Morii N, Shiono S, Itoh H, Sugawara A, Yamada T, Saito Y, Arai H, Imura H (1988) Atrial natriuretic polypeptide in bovine adrenal medulla. Hypertension 11: 692–696
Nakamaru M, Inagami T (1986) Atrial natriuretic factor inhibits norepinephrine release evoked by sympathetic nerve stimulation in isolated perfused rat mesenteric arteries. Eur J Pharmacol 123: 459–461
Nezu M, Miura Y, Adachi M, Adachi M, Kimura S, Toriyabe S, Ishizuka Y, Ohashi J, Sugawara T, Takahashi M, Noshiro T, Yoshinaga K (1985) The effects of epinephrine on norepinephrine release in essential hypertension. Hypertension 7: 187–195
Olesen SP, Clapham DE, Davies PF (1988) Haemodynamic shear stress activates a K+ current in vascular endothelial cells. Nature 331: 168–170
Pruss RM, Zamir N (1987) Regulated expression of atrial natriuretic peptide-like immunoreactivity in cultured bovine adrenomedullary chromaffin cells. Neurochem Int 11: 299–304
Richards AM, Ikram H, Yandle TG, Nicholls MG, Webster MWI, Espiner EA (1985a) Renal, haemodynamic, and hormonal effects of human alpha atrial natriuretic peptide in healthy volunteers. Lancet 1: 545–549
Richards AM, Nicholls MG, Espiner EA, Ikram H, Yandle TG, Joyce SL, Cullens MM (1985b) Effects of alpha-human atrial natriuretic peptide in essential hypertension. Hypertension 7: 812–817
Richards AM, Tonolo G, Montorsi P, Finlayson J, Fraser R, Inglis G, Towrie A, Morton JJ (1988) Low dose infusions of 26- and 28-amino acid human atrial natriuretic peptides in normal man. J Clin Endocrinol Metab 66: 465–472
Riegger GAJ, Kromer EP, Kochsiek K (1986) Human atrial natriuretic peptide: Plasma levels, hemodynamic, hormonal, and renal effects in patients with severe congestive heart failure. J Cardiovasc Pharmacol 8: 1107–1112
Riegger GAJ, Elsner D, Kromer EP, Daffner C, Forssmann WG, Muders F, Pascher EW, Kochsiek K (1988) Atrial natriuretic peptide in congestive heart failure in the dog: plasma levels, cyclic guanosine monophosphate, ultrastrucutre of atrial myoendocrine cells, and J. Holtz hemodynamic, hormonal, and renal effects. Circulation 77: 398–406
Ruskoaho H, Toth M, Lang RE (1985) Atrial natriuretic peptide secretion: synergistic effect of phorbol ester and A23187. Biochem Biophys Res Commun 133: 581–588
Saito Y, Nakao K, Morii N, Sugawara A, Shiono S, Yamada T, Itoh H, Sakamoto M, Kurahashi K, Fujiwara M, Imura H (1986) Bay K 8644, a voltage-sensitive calcium channel agonist, facilitates secretion of atrial natriuretic polypeptide from isolated perfused rat hearts. Biochem Biophys Res Commun 138: 1170–1176
Saito Y, Nakao K, Nishimura K, Sugawara A, Okumura K, Obata K, Sonoda R, Ban T, Yasue H, Imura H (1987) Clinical application of atrial natriuretic polypeptide in patients with congestive heart failure: beneficial effects on left ventricular function. Circulation 76: 115–124
Schiebinger RJ, Linden J (1986a) Effect of atrial contraction frequency on atrial natriuretic peptide secretion. Am J Physiol 251: H1095 - H1099
Schiebinger RJ, Linden J (1986b) The influence of resting tension of immunoreactive atrial natriuretic peptide secretion by rat atria super-fused in vitro. Circ Res 59: 105–109
Schiebinger RJ, Baker MZ, Linden J (1987) Effect of adrenergic and muscarinic cholinergic agonists on atrial natriuretic peptide secretion by isolated rat atria. Potential role of the autonomic nervous system in modulating atrial natriuretic peptide secretion. J Clin Invest 80: 1687–1691
Schultz HD, Gardner DG, Deschepper DF, Coleridge HM, Coleridge JCG (1988) Vagal C-fiber blockade abolishes sympathetic inhibition by atrial natriuretic factor. Am J Pyhsiol 255: R6 - R13
Sonnenberg H, Veress AT (1984) Cellular mechanism of release of atrial natriuretic factor. Biochem Biophys Res Commun 124: 443–449
Takeshita A, Imaizumi T, Nakamura N, Higashi H, Sasaki T, Nakamura M, Kangawa K, Mat-suo H (1987) Attenuation of reflex forearm vasoconstriction by a-human atrial natriuretic peptide in men. Circ Res 61: 555–559
Thorén P, Mark AL, Morgan DA, Neill TP, Needleman AP, Brody MJ (1986) Activation of vagal depressor reflexes by atriopeptins inhibits renal sympathetic nerve activity. Am J Physiol 251: H1252 - H1259
Volpe M, De Luca N, Bigazzi MC, Vecchione F, Lembo G, Condorelli M, Trimarco B (1988) Atrial natriuretic factor potentiates forearm reflex vasoconstriction induced by cardiopul-ANP and the Sympathetic Activity monary receptor deactivation in man. Circulation 77: 849–855
Weidmann P, Hasler L, Gnädinger MP, Lang RE, Uehlinger DE, Shaw S, Rascher W, Reubi FC (1986a) Blood levels and renal effects of atrial natriuretic peptide in normal man. J Clin Invest 77: 734–742
Weidmann P, Hellmueller B, Uehlinger DE, Lang RE, Gnaedinger MP, Hasler L, Shaw S, Bachmann C (1986b) Plasma levels and cardiovascular, endocrine, and excretory effects of atrial natriuretic peptide during different sodium intakes in man. J Clin Endocrinol Metab 62: 1027–1036
Zukowska-Grojec Z, Haass M, Kopin IJ, Zamir N (1986) Interactions of atrial natriuretic peptide with the sympathetic and endocrine systems in the pithed rat. J Pharm Exp Ther 239: 480–487
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1989 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Holtz, J. (1989). Interaction between ANP and the Sympathetic Activity. In: Kaufmann, W., Wambach, G. (eds) Endocrinology of the Heart. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-83858-3_7
Download citation
DOI: https://doi.org/10.1007/978-3-642-83858-3_7
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-51409-1
Online ISBN: 978-3-642-83858-3
eBook Packages: Springer Book Archive